Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Zhi‐Chun Gu"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/8b7f4648e3b94fe492e6ca74636be051
Autor:
Mang-Mang Pan, Chi Zhang, Long Shen, Jing-Jing Sha, Hui Shen, Yi-Dan Yan, Jia Wang, Xin Wang, Hou-Wen Lin, Zhi-Chun Gu
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Atrial fibrillation (AF) is a common arrhythmia that requires anticoagulation therapy to prevent stroke. However, there is still a significant under-/over-treatment in stroke prevention for patients with AF. The adherence and the
Externí odkaz:
https://doaj.org/article/7a8880725bcd46129e5d4d7af1dfcbdc
Autor:
Li-Man Wang, Yan Chen, Li-Li Xu, Meng-Fei Dai, Yi-Jun Ke, Bao-Yan Wang, Lin Zhou, Ji-Fan Zhang, Zhang-Qi Wu, Yu-Jie Zhou, Zhi-Chun Gu, Hang Xu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Percutaneous left atrial appendage occlusion (LAAO) has emerged as a stroke prevention strategy in patients with nonvalvular atrial fibrillation (NVAF), and these patients were required to receive antithrombotic therapy post-procedure. Ho
Externí odkaz:
https://doaj.org/article/6681303c5d734aefb4ae0a7a2e66408c
Autor:
Nan-Nan Shen MS, Eliana Ferroni MS, Claudio Barbiellini Amidei MS, Cristina Canova PhD, Viviana Peron MS, Jia-Liang Wang MS, Hou-Wen Lin PhD, Zhi-Chun Gu MS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Introduction Off-label, under-, and overdosed direct oral anticoagulants (DOACs) are commonly prescribed to patients with atrial fibrillation (AF), but real-world evidence on their effectiveness and safety is limited. Methods MEDLINE, Embase, and Coc
Externí odkaz:
https://doaj.org/article/1cd70e1b24ce41d29fda83ffded08d9e
Autor:
Yi–Dan Yan MSc, Ze Yu MD, Lan-Ping Ding MSc, Min Zhou MD, Chi Zhang MSc, Mang-Mang Pan MSc, Jin-Yuan Zhang MD, Ze-Yuan Wang MD, Fei Gao MD, Hang-Yu Li MD, Guang-Yong Zhang PhD, Hou-Wen Lin PhD, Ming-Gang Wang PhD, Zhi–Chun Gu MSc
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Background The accuracy of current prediction tools for venous thromboembolism (VTE) events following hernia surgery remains insufficient for individualized patient management strategies. To address this issue, we have developed a machine learning (M
Externí odkaz:
https://doaj.org/article/25b8da6c01ff4b6c8c1b69baf1945a94
Autor:
Jia Wang, Yang-Xi Liu, Yi-Dan Yan, Li Liu, Chi Zhang, Mang-Mang Pan, Hou-Wen Lin, Zhi-Chun Gu
Publikováno v:
Journal of Interventional Cardiology, Vol 2023 (2023)
Background. Venous thromboembolism (VTE) is a common cardiovascular disease that seriously threatens human lives. Anticoagulant therapy is considered to be the cornerstone of VTE treatment. An increasing number of studies has been updated in the VTE
Externí odkaz:
https://doaj.org/article/32aa6c9b536940ab97d6add3b54e439d
Autor:
Hao Li, Guo-Ying Chang, Yi-Hong Jiang, Li Xu, Long Shen, Zhi-Chun Gu, Hou-Wen Lin, Fang-Hong Shi
Publikováno v:
International Journal of Public Health, Vol 67 (2022)
Objectives: To simulate the growth trend of diabetes mellitus in Chinese population.Methods: The system dynamic modeling methodology was used to establish a population prediction model of diabetes with or without cardiovascular diseases. Lifestyle th
Externí odkaz:
https://doaj.org/article/bebc366a401b4c03b0493518a7bb2d01
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundDrug-resistance is a significant clinical issue in persons with epilepsy. In the past few years, many studies have been published investigating the management of drug-resistant epilepsy (DRE); however, no systematic and quantitative evaluat
Externí odkaz:
https://doaj.org/article/97dee469bf73412fa1831046e6300948
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 22, Iss 3, Pp 1019-1027 (2021)
The populations included in the randomized controlled clinical trials and observational studies were different. The effectiveness and safety of rivaroxaban for stroke prevention in patients with atrial fibrillation (AF) varied among studies. This stu
Externí odkaz:
https://doaj.org/article/7addf49960004ccdaca067b062d3e787
Autor:
Chi Zhang MM, Jia Wang MM, Ya Yang MD, PhD, Er-Li Ma BS, Hou-Wen Lin MD, PhD, Bing-Long Liu BS, Zhi-Chun Gu MM
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Aim Non-vitamin K antagonist oral anticoagulants (NOACs) were developed as an alternative to warfarin to prevent thromboembolism in patients with atrial fibrillation (AF), prosthetic heart valves, venous thromboembolism (VTE), or other thrombotic dis
Externí odkaz:
https://doaj.org/article/7ca6b04b029447c19180b102ccf0b08a